Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediLite Diagnostika is a private U.S. diagnostics company focused on chemiluminescence-based assay technologies and related diagnostic product development. Available evidence indicates the company has operated since the mid-1990s in California and has developed patented luminescence and chemiluminescence platforms for enzyme- and immunoassay-based detection. The company appears to have worked on assays involving alkaline phosphatase and NAD(P)-linked enzyme systems, and its founder has publicly described a rapid PSA assay developed using MediLite technology. MediLite also appears connected to broader immuno- and molecular-diagnostics activities rather than therapeutic drug development. Public information is sparse, suggesting it is a small, privately held diagnostics business rather than a venture-backed biotech with a disclosed clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediLite Diagnostika.